Description
BLOOD AND BLOOD PRODUCTS IDIQ FOR ICVAHCS
First action · last action
2022-10-01 · 2024-03-31
Transactions
2
First transaction's obligation
$328,325
Base + all options value (sum of deltas)
$156,053
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C26321D0005
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-10-01+$328,325= $328,325
- Mod P000012024-03-31-$172,272= $156,053
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-10-01 | +$328,325 | $328,325 | BLOOD AND BLOOD PRODUCTS IDIQ FOR ICVAHCS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-03-31 | −$172,272 | $156,053 | BLOOD AND BLOOD PRODUCTS IDIQ FOR ICVAHCS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CFN4PQKSBV56)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26326N0219 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $317,178 | FY2026 |
| 36C26326D0013 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25226N0070 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25225N0050 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $330 | FY2025 |
| 36C26325N0085 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $225,725 | FY2025 |
| 36C25224N0030 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $1,253 | FY2024 |
Other recipients under 6550 from NETWORK CONTRACT OFFICE 23 (36C263) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26326P0546 | ROCHE DIAGNOSTICS CORPORATION | NETWORK CONTRACT OFFICE 23 (36C263) | $262,620 | FY2026 |
| 36C26326D0057 | PROMEGA CORPORATION | NETWORK CONTRACT OFFICE 23 (36C263) | $0 | FY2026 |
| 36C26326N0540 | PROMEGA CORPORATION | NETWORK CONTRACT OFFICE 23 (36C263) | $24,378 | FY2026 |
| 36C26326N0012 | BIOMERIEUX INC | NETWORK CONTRACT OFFICE 23 (36C263) | $70,608 | FY2026 |
| 36C26326N0005 | MICROGENICS CORPORATION | NETWORK CONTRACT OFFICE 23 (36C263) | $165,318 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26323N0100_3600_36C26321D0005_3600 · retrieved 2026-09-26.